LMNX
Defiance Daily Target 2X Long LMND ETF
Set alert
9.16 USD +0.01 +0.09%
9.16 Day range 9.96
6.90 52-week range 55.00
- YTD
- -69.19%
- 1 year
- -43.88%
- Open
- 9.21
- Prev close
- 9.15
- Mkt cap
- 1.10M
- Vol
- 16.61K
- Avg vol
- 52.22K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.16
- High
- 9.96
- Earnings
- Aug 3, 2021
Next earnings
Aug 3, 2021
Expected Aug 3, 2021. Consensus EPS estimate 0.21.
Financials — quick view
LMNX Revenue — quarterly 110.69M
LMNX Net income — quarterly 8.90M
LMNX EPS — quarterly 0.19
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 3, 2021 | Jun 1, 2021 | 0.21 | — | — | — |
| May 5, 2021 | Mar 1, 2021 | 0.15 | — | — | — |
| Feb 8, 2021 | Dec 1, 2020 | 0.14 | — | — | — |
| Nov 5, 2020 | Sep 1, 2020 | 0.21 | — | — | — |
| Aug 4, 2020 | Jun 1, 2020 | 0.08 | — | — | — |
| May 4, 2020 | Mar 1, 2020 | 0.04 | — | — | — |
News
- AdaptHealth Appoints Harriss Currie as Chief Financial Officer
- Defiance ETFs Announces Closure of Select Funds
- Contrasting Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Biostage (OTCMKTS:BSTG)
- Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) & Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) Critical Comparison
- Financial Contrast: Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) vs. Minerva Surgical (NASDAQ:UTRS)
- 5 Best-Performing Leveraged ETFs of Last Week
- Best-Performing Leveraged ETFs of Last Week
- Defiance Launches LMNX: The First 2X Long ETF for Lemonade, Inc.
- Earnings Scheduled For November 5, 2020
- Stocks That Hit 52-Week Highs On Wednesday
Your note
Sign in to keep a note on LMNX — it syncs with the Stock Master app.